VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, announced that the independent Data and Safety Monitoring Board (DSMB) completed its second safety assessment of the ongoing Phase 1/2a clinical study of VBI-1901 in recurrent GBM.
ManagingLife Announces Collaboration with Sun Life
ProteinQure Announces Collaboration with Fujitsu Labs
Reviewing OBIO's Workshop: "No Project Was Ever Completed On Time and Within Budget." - Cheops Law
On September 18th, OBIO organized a workshop with two industry experts and provided the CFO perspective on budgeting for start-up and growing health science companies.
John Jordan (CFO, RNA Diagnostics) and Jim Cooke (Partner, Stoneybridge Partners) addressed 3 main areas – how to build a robust budget, how to present a budget to the board and to investors and how to manage a budget.
CABHI announces new Mentorship, Capital and Continuation Program
The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest and in partnership with National Bank, announced the launch of a new Mentorship, Capital and Continuation Program (MC2). MC2 will accelerate market-ready healthcare innovations for the aging population from bench to bedside more quickly and efficiently.
Awake Labs Announces Collaboration with Holland Bloorview Kids Rehabilitation Hospital
Awake Labs (OBIO Pre-CAAP 2018 Company), Holland Bloorview Kids Rehabilitation Hospital – with support from the Ontario Brain Institute (OBI) – have come together to bring a new technology to the autism community via a pilot with a local community partner.
Trexo Robotics Featured as Top 10 Most Innovative Medical Device Companies in 2018
Impact Centre Releases Report "Scaling Up - Growth Metrics for Software Companies"
TranQool Reaches 1.3 Million Canadians After Acquisition
Register Now for the MedTech Canada Innovation Breakfast Seminar, Sept 24
Register Now for McMaster University's Diagnostics Workshop, Sept 26-27
2018 Manning Innovation Awards Nominates Two OBIO Members
Jessica Ching (Eve Kit, OBIO CAAP 2013 Company) and Noureddin Chahrour (AdrenalEase, OBIO Pre-CAAP 2018 Company) have been nominated in the Toronto Region category for the 2018 Manning Innovation Awards. The winners will be announced later this fall, and will be celebrated at the 2018 Manning Innovation Awards Dinner on October 24, 2018.
Elucid Labs Announced as a Finalist in ElevatR Pitch Competition
Elucid Labs was named a finalist for the 2018 ElevatR Pitch Competition run by Elevate TechFest, and will compete for over $1M in potential funding.